medigraphic.com

2016, Número 5

<< Anterior Siguiente >>

Rev Med Inst Mex Seguro Soc 2016; 54 (5)


Prevalencia de síndrome metabólico y factores asociados en niños y adolescentes con obesidad

Romero-Velarde E, Aguirre-Salas LM, Álvarez-Román YA, Vásquez-Garibay EM, Casillas-Toral E, Fonseca-Reyes S

Idioma: Español
Referencias bibliográficas: 27
Paginas: 568-575
Archivo PDF: 302.14 Kb.


RESUMEN

Introducción: la prevalencia de sobrepeso y obesidad es elevada en niños y adolescentes en nuestro país, así como las alteraciones asociadas a su presencia. El objetivo del presente trabajo fue estimar la prevalencia de síndrome metabólico en niños y adolescentes con obesidad que acudieron a una clínica hospitalaria e identificar factores asociados a su presencia.
Métodos: diseño transversal con 120 niños y adolescentes, de cualquier sexo, con obesidad exógena e IMC › 2.0 desviaciones estándar. Se recolectaron antecedentes personales y familiares; se midió la presión arterial y se realizaron determinaciones de los niveles séricos de glucosa, insulina, lipoproteínas de colesterol de alta densidad y triglicéridos. Se identificó la presencia de síndrome metabólico con los criterios ATPIII, OMS y de la Federación Internacional de Diabetes. Se identificó la asociación del síndrome metabólico con diferentes variables con la prueba Chi cuadrada y cálculo de razón de momios.
Resultados: la edad promedio fue de 10.6 ± 2.7 años. La prevalencia de síndrome metabólico fue de 37.5 a 54.5%, dependiendo del criterio utilizado; se asoció al antecedente de peso grande al nacimiento (RM = 2.21 [1.01-4.82]) y resistencia a la insulina (RM = 6.53 [2.40- 18.2]).
Conclusiones: la prevalencia de síndrome metabólico es elevada en este grupo de niños y adolescentes con obesidad. El antecedente de peso grande al nacer y la presencia de resistencia a la insulina nos deben alertar sobre la presencia de la enfermedad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112: 2735-52.

  2. De Ferranti SD, Osganian SK. Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus. Diab Vasc Dis Res. 2007;4:285-96.

  3. D’ Adamo E, Santoro N, Caprio S. The metabolic syndrome in pediatrics: old concepts revised, new concepts discussed. Ped Clin N Am. 2011;58:1241-55.

  4. Pan Y, Pratt CA. Metabolic syndrome and its association with diet and physical activity in US adolescents. J Am Diet Assoc. 2008;108:276-86.

  5. Cook S, Auinger P, Li C, Ford ES. Metabolic syndrome rates in the United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr. 2008;152:165-70.

  6. Tailor AM, Peeters PHM, Norat T, Vineis P, Romaguera D. An update on the prevalence of the metabolic syndrome in children and adolescents. Int J Ped Ob. 2010;5:202-13.

  7. Halley CE, Borges G, Talavera JO, Orozco R, Vargas- Alemán C, Huitrón-Bravo G, et al. Body mass index and the prevalence of metabolic syndrome among children and adolescents in two Mexican populations. J Adolesc Health. 2007;40:521-26.

  8. Juárez-López C, Klünder-Klünder M, Medina-Bravo P, Madrigal-Azcárate A, Mass-Díaz E, Flores- Huerta S. Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents. BMC Public Health. 2010,10:318.

  9. Tailor AM, Peeters PHM, Norat T, Vineis P, Romaguera D. An update on the prevalence of the metabolic syndrome in children and adolescents. Int J Pediatr Obes. 2010;5:202-13.

  10. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classificatión of Diabetes Mellitus. Geneva. Geneva: WHO Department of Noncommunicable Disease Surveillance; 1999.

  11. Zimmet P, Alberti K, George MM, Kaufman F, Tajima N, Silink M, et al; IDF Consensus Group. The metabolic syndrome in children and adolescents- an IDF consensus report. Ped Diab. 2007;8:299-306.

  12. National High blood pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth Report on the Diagnosis, Evaluation and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics. 2004; 114:555-76.

  13. World Health Organization. Training course on child growth assessment. Geneva, WHO, 2008.

  14. Brar PC, Mengwall L, Franklin BH, Fierman AH. Screening obese children and adolescents for prediabetes and/or type 2 diabetes in pediatric practices: a validation study. Clin Pediatr. 2014;53:771-6.

  15. Yamamoto-Kimura L, Posadas-Romero C, Posada- Sánchez R, Zamora-González J, Cardoso-Saldaña G, Méndez RI. Prevalence and interrelations of cardiovascular risk factors in urban and rural Mexican adolescents. J Adolesc Health. 2006;38:591-8.

  16. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattingney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med. 1999;338:1650-6.

  17. Varvarigou AA. Intrauterine growth restriction as a potential risk factor for disease onset in adulthood. J Pediatr Endocrinol Metab. 2010;23:215-24.

  18. Hirschler V, Bugna J, Roque M, et al. Does low birth weight predict obesity/overweight and metabolic syndrome in elementary school children? Arch Med Res. 2008;39:796-802.

  19. Boney CM, Verma A, Tucker R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115:e290-296.

  20. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988– 1994. Arch Pediatr Adolesc Med 2003:157:821-7.

  21. Messiah SE, Arheart KL, Luke B, Lipshultz SE, Miller TL. Relationship between body mass index and metabolic syndrome risk factors among US 8-to 14-years-olds, 1999 to 2002. J Pediatr. 2008;153: 215-221.

  22. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999;103:1175-82.

  23. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Tajsali SE, Yeckel CW et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004; 350:2362-74.

  24. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51:7-18.

  25. Shaibi GQ, Goran MI. Examining metabolic syndrome definitions in overweight hispanic youth: a focus on insulin resistance. J Pediatr. 2008;152:171-6.

  26. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, MCCrindle B et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement of the American Heart Association Atherosclerosis, Hypertension and Obesity in the Young Committee on the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Phyisical Activity, and Metabolism. Circulation. 2009;119:628-47.

  27. Kelly AS, Barlow SE, Rao G, Inge TH, Hayman LL, Steinberger J et al. Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches. A scientific statement of the American Heart Association. Circulation. 2013; 128:1689-1712.




2020     |     www.medigraphic.com